Lumen Bioscience, a clinical-stage biopharma company, announced results from a research collaboration with Google that applied machine learning (ML) to significantly advance the scalability of spirulina-based biologic drugs. The research, led by Caitlin Gamble, Lumen and Drew Bryant at Google Accelerated Science, was funded in part by the Bill & Melinda Gates Foundation. Lumen Bioscience received $2 million of additional grant funding from the Department of Energy to support further devel...